title: Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma.
abstract: Tyrosine kinase inhibitors sunitinib and pazopanib are used as first-line agents in the treatment of metastatic renal cell carcinoma. Treatment-related toxicities have been described with both these drugs. This report describes a patient with metastatic renal carcinoma who developed trismus while being treated with these agents and is, to the best of our knowledge, the first such case to be reported.
authors.affiliation: The Gastrointestinal Unit, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.
authors.forename: Ridhima
authors.initials: R
authors.lastname: Iyer
authors.affiliation: Department of Urology, Frimley Health NHS Foundation Trust, Frimley, Surrey, GU16 7UJ, UK.
authors.forename: Bruce
authors.initials: B
authors.lastname: Montgomery
authors.affiliation: Targeted Cancer Therapy, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7WG, UK.
authors.forename: Hardev S
authors.initials: HS
authors.lastname: Pandha